| ZFIN ID: ZDB-EXP-170208-1 |
Experiment Conditions Description: chemical treatment by diet: 3,3',5-triiodo-L-thyronine
| chemical treatment by diet: 3,3',5-triiodo-L-thyronine |
|---|
| Name: | chemical treatment by diet |
|---|---|
| Synonyms: | |
| Definition: | Chemical treatment condition in which the chemical is introduced through the diet. |
| Ontology: | Zebrafish Environment Condition Ontology [ZECO:0000239] |
| Name: | 3,3',5-triiodo-L-thyronine |
|---|---|
| Synonyms: | 3,3',5-triiodo-L-thyronine, 3,5,3'-Triiodo-L-thyronine, 3,5,3'-Triiodothyronine, 3,5,3'TRIIODOTHYRONINE, 4-(4-hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine, L-3,5,3'-Triiodothyronine, L-T3, liothyronine, liothyroninum, liotironina, O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine, T3, Tertroxin, Tresitope, Triiodothyronine |
| Definition: | An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism. |
| Ontology: | ChEBI [CHEBI:18258] ( EBI ) |
| Publication: | Guillot et al., 2016 |
|---|